Loading...

NEXTGEN AML STRATIFICATION NGS PANEL

image not found

NABL Cap Accredited 
The NextGen AML Stratification NGS Panel at Metropolis Healthcare is an advanced molecular test designed to identify genetic mutations associated with Acute Myeloid Leukemia (AML). This panel detects clinically significant mutations that help classify AML subtypes, assess prognosis, and guide targeted therapy selection. Metropolis Healthcare uses high-depth Next-Generation Sequencing with robust bioinformatics to ensure accurate and actionable results. It is ideal for newly diagnosed AML patients or those requiring detailed molecular characterization for therapy planning.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA Whole Blood , EDTA Bone Marrow

Fasting Not Required


Notes:N8228

Frequently Asked Questions (FAQ's):

What does the AML Stratification NGS Panel at Metropolis Healthcare include?
It analyzes multiple AML-associated genes to detect mutations critical for classification, prognosis, and treatment guidance.

How does Metropolis Healthcare perform this AML gene panel?
Metropolis Healthcare uses high-depth NGS with validated bioinformatics pipelines to ensure precise detection of relevant mutations.

Who should consider taking this test at Metropolis Healthcare?
Newly diagnosed AML patients or those needing molecular profiling for risk stratification and therapy selection should consider this panel.

Is fasting required for the AML Stratification NGS Panel at Metropolis Healthcare?
No fasting is required; the test is performed on blood or bone marrow samples.

How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to detailed sequencing and mutation interpretation.

Can this test at Metropolis Healthcare help guide AML treatment decisions?
Yes, identifying mutations informs prognosis, targeted therapy selection, and treatment intensity.

How accurate is the AML NGS panel at Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through deep sequencing coverage and rigorous quality control protocols.

Does this test support long-term AML management at Metropolis Healthcare?
Yes, molecular insights assist in therapy planning, monitoring, and personalized disease management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab